| Current Price | $123.56 | Mkt Cap | $165.7B |
|---|---|---|---|
| Open | $123.12 | P/E Ratio | 42.83 |
| Prev. Close | $123.56 | Div. (Yield) | $2.52 (2.0%) |
| Daily Range | $122.05 - $123.61 | Volume | 4,182,111 |
| 52-Wk Range | $98.94 - $135.89 | Avg. Daily Vol. | 4,162,988 |
| Current Price | $123.56 | Mkt Cap | $165.7B |
|---|---|---|---|
| Open | $123.12 | P/E Ratio | 42.83 |
| Prev. Close | $123.56 | Div. (Yield) | $2.52 (2.0%) |
| Daily Range | $122.05 - $123.61 | Volume | 4,182,111 |
| 52-Wk Range | $98.94 - $135.89 | Avg. Daily Vol. | 4,162,988 |
The best Bull and Bear pitches based on recency and number of recommendations.
Look out for Medtronic. It's not a sexy biotech, but it's a monster.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about MDT.
Recs
BRIDividends
(41.46)
Submitted: 10/25/2021 4:29:48 PM :
Start Price:
$123.12
NYSE:MDT Score:
+0.10
The BRI Dividend portfolio includes S&P500 stocks that meet the following criteria:
- Dividend Growth for 10 or more years;
- Dividend Chowder (dividend yield plus 5 year dividend growth rate) of 7% or more;
- Payout Ratio (earnings based) of less than 60; and
- Passes certain BRI screenings (including certain weapons, alcohol, tobacco, gambling, certain medical products and immoral businesses).
The resulting portfolio should be a mix of large blue chip dividend growth companies that meet biblically responsible investing criterias.
Recs
TMFkodyk123
(34.02)
Submitted: 7/23/2021 2:13:56 PM :
Start Price:
$127.96
NYSE:MDT Score:
-7.00
Medtronic is positioned to benefit from an aging global population and strong demand for healthcare going forward as a result. The company's commitment to innovation and steady launch of quality products to address serious medical conditions should help deliver mid-single-digit annual revenue growth and high-single-digit annual earnings growth in the years ahead, which will outperform the S&P 500 considering the company is trading near fair value and offers a 2% dividend yield.
Recs
TMFjimhalley
(20.37)
Submitted: 5/31/2021 3:15:42 PM :
Start Price:
$126.81
NYSE:MDT Score:
-10.35
The company has seen strong growth in revenue in the most recent quarter, meaning that it is poised to do better this year as more medical procedures are performed after a year when they were delayed because of COVID-19. Also, the company's emphasis on diabetes care has trends in its favor.
Find the members with the highest scoring picks in MDT.
TheFall2021 (84.74) Score: +15.46
The Score Leader is the player with the highest score across all their picks in MDT.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TheFall2021 | 84.74 | 12/21/2020 |
|
5Y | $113.01 | +9.34% | +24.80% | +15.46 | 0 Comment | |
| BRIDividends | 41.46 | 10/25/2021 |
|
5Y | $123.12 | +0.36% | +0.26% | +0.10 | 1 Comment | |
| IMGNE | 60.44 | 10/19/2021 |
|
5Y | $122.05 | +1.24% | +1.17% | +0.07 | 0 Comment | |
| Melsel3 | < 20 | 6/14/2021 |
|
5Y | $122.05 | +1.24% | +7.64% | -6.40 | 0 Comment | |
| PAGEBOY54 | 95.77 | 7/26/2021 |
|
5Y | $127.66 | -3.21% | +3.68% | -6.89 | 0 Comment | |
| 2sonik | 37.81 | 8/23/2021 |
|
1Y | $129.53 | -4.61% | +2.32% | -6.92 | 0 Comment | |
| TMFkodyk123 | 34.02 | 7/23/2021 |
|
5Y | $127.96 | -3.44% | +3.56% | -7.00 | 1 Comment | |
| adasand | 94.22 | 7/14/2021 |
|
5Y | $127.43 | -3.03% | +4.13% | -7.16 | 0 Comment | |
| Moermanski | < 20 | 10/5/2021 |
|
5Y | $126.96 | -2.68% | +4.69% | -7.37 | 0 Comment | |
| aldwords | 61.61 | 7/19/2021 |
|
5Y | $124.22 | -0.53% | +6.87% | -7.40 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
